The government wants AI to fix health care's most hated chore
If you have ever waited days for an insurer to sign off on a medication or a procedure, you already know the villain of today's news: prior authorization. It is the pre-approval step that sits between what your doctor recommends and the treatment you actually receive — and it is one of the most reliably frustrating experiences in American health care. Now the federal government is testing whether artificial intelligence can take that chore off everyone's hands, and it is starting where it has the most direct control: Medicare.
The two developments landing today are really two windows onto the same experiment. Uncle Sam is betting that AI can untangle the tangle — automating the back-and-forth that insurers use to approve or deny coverage for treatments. And the arrival of AI in insurance approvals is beginning, pointedly, with Medicare, the program that covers tens of millions of older Americans and sets the tone for how the rest of the industry behaves.
Why prior authorization is the right target
Prior authorization is the process insurers use to decide whether they will pay for a given treatment before it happens. In theory it is a check against waste and unnecessary care. In practice, it has become a byword for delay: forms, faxes, phone calls, and days or weeks of limbo while a doctor's recommendation waits for a green light. It frustrates patients, buries clinicians in paperwork, and slows down care that may be time-sensitive.
That combination — high volume, heavy manual effort, and enormous frustration — is exactly what makes it an attractive candidate for automation. If software can read the request, check it against the rules, and return an answer quickly, the theory goes, everyone wins: patients get faster decisions, doctors reclaim time, and the system sheds a layer of friction it has carried for decades.
The promise, and the reason to watch closely
The optimistic case is straightforward. AI is well suited to the repetitive, rules-based matching that prior authorization involves, and speeding up approvals could meaningfully improve the experience of getting care. A government-run test is also notable because it puts a public actor — not just private insurers — in the position of proving whether the technology actually helps.
But approvals are only half the equation. The same machinery that grants coverage can also deny it, and handing that judgment to an algorithm raises real stakes. When AI stands between a doctor's recommendation and a patient's treatment, the questions that matter are the ones today's reports put front and center: How accurate is it? How transparent are its decisions? And what happens when it says no?
The bottom line
Starting with Medicare is a telling choice. It is the largest single lever the government has, and whatever standards emerge there tend to ripple outward across the insurance industry. Today's news is less a finished product than a signal of direction: the most hated chore in health care is now an AI test case, and how this experiment handles denials — not just approvals — will determine whether it is remembered as a genuine fix or simply a faster way to hear no. For now, it is a story worth watching, because the outcome will touch nearly anyone who has ever needed a treatment approved.